Device Orthodontics

Invisalign

Payments companies reported to CMS as associated with Invisalign. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$52Massociated payments (2023-2025)
37,914clinicians with associated payments
1company reporting

By year

2023 $13M
2024 $17M
2025 $23M

Payments reported as associated with Invisalign, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $23M
General Practice (Dentist) $18M
Dentist $9.7M
Pediatric Dentistry $267K
Dental Public Health $162K
Prosthodontics $43K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Invisalign

These are the largest totals companies reported as associated with Invisalign. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Ryan Molis Burr Ridge, IL General Practice (Dentist) $8,791,170.10
Mazyar Moshiri Saint Louis, MO Orthodontics and Dentofacial Orthopedics $2,305,841.32
Jonathan Nicozisis Princeton, NJ Orthodontics and Dentofacial Orthopedics $2,261,304.05
David Galler Woodmere, NY Dentist $2,100,502.47
Michael Florman Santa Monica, CA Orthodontics and Dentofacial Orthopedics $1,653,816.37
Jason Gladwell Wake Forest, NC Orthodontics and Dentofacial Orthopedics $1,632,257.80
Corey Anolik Philadelphia, PA General Practice (Dentist) $1,543,382.04
Robert Boyd San Francisco, CA Orthodontics and Dentofacial Orthopedics $1,500,000.00
David Boschken San Jose, CA Orthodontics and Dentofacial Orthopedics $1,332,453.80
Christina Dean Frisco, TX General Practice (Dentist) $1,110,152.82

Prescribed Invisalign?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.